GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Medical Services Holdings Ltd (NYSE:CCM) » Definitions » Revenue

CCM (Concord Medical Services Holdings) Revenue : $65.58 Mil (TTM As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Concord Medical Services Holdings Revenue?

Concord Medical Services Holdings's revenue for the six months ended in Jun. 2024 was $30.16 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $65.58 Mil. Concord Medical Services Holdings's Revenue per Share for the six months ended in Jun. 2024 was $6.91. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $15.01.

Warning Sign:

Concord Medical Services Holdings Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Concord Medical Services Holdings was -24.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 30.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 27.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was -4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Concord Medical Services Holdings's highest 3-Year average Revenue per Share Growth Rate was 39.80% per year. The lowest was -33.10% per year. And the median was 4.60% per year.


Concord Medical Services Holdings Revenue Historical Data

The historical data trend for Concord Medical Services Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Medical Services Holdings Revenue Chart

Concord Medical Services Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.28 34.10 76.25 67.71 75.26

Concord Medical Services Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.55 47.02 39.73 35.42 30.16

Competitive Comparison of Concord Medical Services Holdings's Revenue

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Medical Services Holdings's Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's Revenue falls into.



Concord Medical Services Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $65.58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Medical Services Holdings  (NYSE:CCM) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Concord Medical Services Holdings Revenue Related Terms

Thank you for viewing the detailed overview of Concord Medical Services Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Medical Services Holdings Business Description

Traded in Other Exchanges
N/A
Address
Hanwei Building, No. 7 Guanghua Road, Room 26A1-26A5, East Area, Chaoyang District, Beijing, CHN, 100013
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.